These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3487661)

  • 1. [A case of chronic myeloid leukemia in blastic crisis with B-cell markers].
    Ishiyama T; Sugimoto M; Wakabayashi Y; Hirose S; Ishida Y; Satoh H
    Rinsho Ketsueki; 1986 Feb; 27(2):215-8. PubMed ID: 3487661
    [No Abstract]   [Full Text] [Related]  

  • 2. [Detection of B-cell antigen on the blast cells in chronic myeloid leukemia].
    Morozova LF; Belianchikova NI; Radzikhovskaia RM; Baryshnikov AIu; Volkova MA
    Biull Eksp Biol Med; 1979 Jun; 87(6):574-6. PubMed ID: 380683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Childhood chronic myelogenous leukemia with blastic crisis showing pre-B cell and myelocytic phenotypes].
    Nakadate H; Kobayashi R; Yanazume M; Nishi M; Hattori T; Hatae Y; Takeda T
    Rinsho Ketsueki; 1987 Jan; 28(1):76-80. PubMed ID: 3494864
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of blast crisis of chronic myelogenous leukemia with lymphoid blasts possessing B-cell markers (author's transl)].
    Ohno R; Ueda R; Suzuki H; Tanaka M; Ezaki K; Kawashima K; Yamada K; Yoshikawa H; Shamoto M; Kawabe M
    Rinsho Ketsueki; 1978 Feb; 19(2):166-71. PubMed ID: 306451
    [No Abstract]   [Full Text] [Related]  

  • 5. [Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis].
    Baryshnikov AIu
    Eksp Onkol; 1984; 6(5):53-5. PubMed ID: 6239771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of chronic granulocytic leukemia in lymphoblastic crisis with B-cell markers (author's transl)].
    Katsuki T; Morinaga S; Kimoto M; Yamaguchi H; Asai I; Tsukada T; Endo Y; Kamiyama R
    Rinsho Ketsueki; 1981 Jul; 22(7):1182-7. PubMed ID: 6977048
    [No Abstract]   [Full Text] [Related]  

  • 7. Maturation of B-lineage blast crisis cells in chronic myeloid leukemia.
    Ng CS; Chan JK; Arnold M
    Am J Hematol; 1987 Jun; 25(2):231-3. PubMed ID: 3111248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
    Kozlov I; Beason K; Yu C; Hughson M
    Cancer Genet Cytogenet; 2005 Nov; 163(1):62-7. PubMed ID: 16271957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute clinical crisis and malignant cytology in chronic myeloid leukemia. Hematological considerations on the significance of "blastic crisis" in 25 cases].
    Sanchez-Fayos J; Outeiriño J; Paniagua G; Calabuig MT; Martinez Frejo MC
    Sangre (Barc); 1970; 15(2):209-25. PubMed ID: 5271128
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute clinical crisis and malignant cytology in chronic myeloid leukemia. Hematological considerations on the significance of "blastic crisis" in 25 cases].
    Sanchez-Fayos J; Outeiriño J; Paniagua G; Calabuig T; Martinez Frejo C
    Sangre (Barc); 1970; 15(2):209-25. PubMed ID: 5270389
    [No Abstract]   [Full Text] [Related]  

  • 11. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.
    Nadler LM; Anderson KC; Marti G; Bates M; Park E; Daley JF; Schlossman SF
    J Immunol; 1983 Jul; 131(1):244-50. PubMed ID: 6408173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells and probably B cells arise from the malignant clone in chronic myelogenous leukemia.
    Fauser AA; Kanz L; Bross KJ; Löhr GW
    J Clin Invest; 1985 Mar; 75(3):1080-2. PubMed ID: 3920244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A marker of neutrophil heterogeneity reveals two forms of chronic myelogenous leukemia.
    Gallin JI; Jacobson RJ; Seligmann B; Metcalf JA; McKay J; Sacher RA; Malech HL
    Trans Assoc Am Physicians; 1985; 98():166-70. PubMed ID: 3870297
    [No Abstract]   [Full Text] [Related]  

  • 14. Monoclonal antibody against myeloid leukemia cell line (KG-1).
    Aota F; Chang D; Hill NO; Khan A
    Cancer Res; 1983 Mar; 43(3):1093-6. PubMed ID: 6572095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Terminal DNA nucleotidyltransferase in blastic crisis in myelocytic leukemia].
    Rudzka E; Bartnikowa W; Hołowiecki J; Japa J; Schneiberg K
    Acta Haematol Pol; 1981; 12(2):97-101. PubMed ID: 6946663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell malignancies and differentiation antigens defined with monoclonal antibodies.
    Kikuchi K; Koshiba H; Kasai K; Hiratsuka H; Fujimoto N; Uede T
    Jpn J Clin Oncol; 1983 Sep; 13(3):517-31. PubMed ID: 6417375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
    Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in cell surface glycoproteins and antigens during differentiation of the human myeloid leukemia cell lines ML-1, ML-2, and HL-60.
    Stöckbauer P; Gahmberg CG; Andersson LC
    Cancer Res; 1985 Jun; 45(6):2821-6. PubMed ID: 3857122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Thy-1 antigen: cell surface expression on early T and B lymphocytes.
    Ritter MA; Sauvage CA; Delia D
    Immunology; 1983 Jul; 49(3):555-64. PubMed ID: 6134665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different stages of B cell differentiation in non-T acute lymphoblastic leukemia.
    Foa R; Migone N; Saitta M; Fierro MT; Giubellino MC; Lusso P; Cordero di Montezemolo L; Miniero R; Lauria F
    J Clin Invest; 1984 Nov; 74(5):1756-63. PubMed ID: 6438157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.